We aim to be the leading specialty pharmaceutical group to improve the quality of human life
Investor Relations
Corporate Information
Financial Information
Stock Information
Newsroom
Webcasting
Information Request

Email This Print This Stock Fundamentals

Historical EPS ($) a
0.02372
NAV ($) b
0.3195
Historical PE
26.771
Price / NAV b
1.987
Dividend ($) d
0.006071
52 Weeks High
0.745
Dividend Yield (%) d
0.956
52 Weeks Low
0.470
Par Value ($)
USD 0.020
Market Cap (M)
312.906
Issued & Paid-up Shares c
492,765,000

Notes
  1. Based on latest Full Year results announcement.
  2. Based on latest results announcement (Full Year, Half Year or Interim).
  3. Rounded to the nearest thousand. Updated on 15/05/2008
  4. Dividend is based on latest Full Year results announcement and excludes special dividend.

IPO Information

Listing Date
May 05, 2004
Subscription Rate
97.90
IPO Price
0.280
Current vs IPO Price (%)
126.79
First Day Close
0.390
First Day Gain (%)
39.3
First Week Close
0.465
First Week Gain (%)
66.1